Bio Techne Corp Stock Market Value
| TECH Stock | USD 72.76 0.93 1.29% |
| Symbol | Bio |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bio Techne 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Techne's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Techne.
| 11/01/2024 |
| 01/30/2025 |
If you would invest 0.00 in Bio Techne on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Bio Techne Corp or generate 0.0% return on investment in Bio Techne over 90 days. Bio Techne is related to or competes with Biomarin Pharmaceutical, Vaxcyte, Liquidia Technologies, Legend Biotech, Alnylam Pharmaceuticals, Exelixis, and Halozyme Therapeutics. Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instrum... More
Bio Techne Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Techne's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Techne Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 9.49 | |||
| Value At Risk | (3.71) | |||
| Potential Upside | 3.85 |
Bio Techne Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Techne's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Techne's standard deviation. In reality, there are many statistical measures that can use Bio Techne historical prices to predict the future Bio Techne's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.05) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Techne Corp Backtested Returns
Bio Techne Corp secures Sharpe Ratio (or Efficiency) of -0.0147, which signifies that the company had a -0.0147 % return per unit of risk over the last 3 months. Bio Techne Corp exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bio Techne's Standard Deviation of 2.18, risk adjusted performance of (0.01), and Mean Deviation of 1.56 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.78, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bio Techne's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bio Techne is expected to be smaller as well. At this point, Bio Techne Corp has a negative expected return of -0.032%. Please make sure to confirm Bio Techne's accumulation distribution, and the relationship between the potential upside and day median price , to decide if Bio Techne Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.22 |
Weak predictability
Bio Techne Corp has weak predictability. Overlapping area represents the amount of predictability between Bio Techne time series from 1st of November 2024 to 16th of December 2024 and 16th of December 2024 to 30th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Techne Corp price movement. The serial correlation of 0.22 indicates that over 22.0% of current Bio Techne price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 4.21 |
Bio Techne Corp lagged returns against current returns
Autocorrelation, which is Bio Techne stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bio Techne's stock expected returns. We can calculate the autocorrelation of Bio Techne returns to help us make a trade decision. For example, suppose you find that Bio Techne has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bio Techne regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bio Techne stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bio Techne stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bio Techne stock over time.
Current vs Lagged Prices |
| Timeline |
Bio Techne Lagged Returns
When evaluating Bio Techne's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bio Techne stock have on its future price. Bio Techne autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bio Techne autocorrelation shows the relationship between Bio Techne stock current value and its past values and can show if there is a momentum factor associated with investing in Bio Techne Corp.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:Check out Bio Techne Correlation, Bio Techne Volatility and Bio Techne Alpha and Beta module to complement your research on Bio Techne. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Bio Techne technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.